Clinical Trial Update: S9700 Combination Chemotherapy in Treating Patients With Stage II or Stage III Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of S9700 combination chemotherapy for stage II or III pancreatic cancer has completed; results are not provided in the available snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED